BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rössle M, Siegerstetter V, Euringer W, Olschewski M, Kromeier J, Kurz K, Langer M. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients. Acta Radiol. 2006;47:660-666. [PMID: 16950701 DOI: 10.1080/02841850600806324] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Rabei R, Mathevosian S, Tasse J, Madassery S, Arslan B, Turba U, Ahmed O. Primary constrained TIPS for treating refractory ascites or variceal bleeding secondary to hepatic cirrhosis. Br J Radiol 2018;91:20170409. [PMID: 29166137 DOI: 10.1259/bjr.20170409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Seifert LL, Görlich D, Jansen C, Ortmann O, Schoster M, Praktiknjo M, Gu W, Schindler P, Köhler M, Maschmeier M, Wilms C, Meyer C, Schmidt HH, Wildgruber M, Trebicka J, Heinzow H. Evaluation of impact of elective invasive examinations in patients with transjugular intrahepatic portosystemic shunt in the long-term follow up. Z Gastroenterol 2021;59:24-34. [PMID: 33429447 DOI: 10.1055/a-1330-9867] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Qi XS, Bai M, Yang ZP, Fan DM. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. World J Gastroenterol. 2014;20:6470-6480. [PMID: 24914368 DOI: 10.3748/wjg.v20.i21.6470] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
4 Ding PX, Li Z, Zhang SJ, Han XW, Wu Y, Wang ZG, Fu MT. Outcome of the Z-expandable metallic stent for Budd-Chiari syndrome and segmental obstruction of the inferior vena cava. Eur J Gastroenterol Hepatol. 2016;28:972-979. [PMID: 27172449 DOI: 10.1097/meg.0000000000000640] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
5 Saad WE, Darcy MD. Transjugular Intrahepatic Portosystemic Shunt (TIPS) vs Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices. Semin Intervent Radiol. 2011;28:339-349. [PMID: 22942552 DOI: 10.1055/s-0031-1284461] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 8.1] [Reference Citation Analysis]
6 Schultheiß M, Giesler M, Maruschke L, Schmidt A, Sturm L, Thimme R, Rössle M, Bettinger D. Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization. Cardiovasc Intervent Radiol 2019;42:729-36. [PMID: 30788517 DOI: 10.1007/s00270-019-02176-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Krajina A, Hulek P, Fejfar T, Valek V. Quality improvement guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS). Cardiovasc Intervent Radiol. 2012;35:1295-1300. [PMID: 23070105 DOI: 10.1007/s00270-012-0493] [Reference Citation Analysis]
8 Weber CN, Nadolski GJ, White SB, Clark TW, Mondschein JI, Stavropoulos SW, Shlansky-Goldberg RD, Trerotola SO, Soulen MC. Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts. J Vasc Interv Radiol. 2015;26:1257-65; quiz 1265. [PMID: 25990133 DOI: 10.1016/j.jvir.2015.04.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
9 Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Qi X, Bai M, Wu K, Fan D. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol. 2010;25:1718-1725. [PMID: 21039832 DOI: 10.1111/j.1440-1746.2010.06400.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 8.4] [Reference Citation Analysis]
10 Zhang F, Wang C, Li Y. The outcomes of interventional treatment for Budd-Chiari syndrome: systematic review and meta-analysis. Abdom Imaging. 2015;40:601-608. [PMID: 25248791 DOI: 10.1007/s00261-014-0240-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
11 Gordon BM, Fishbein MC, Levi DS. Polytetrafluoroethylene-covered stents in the venous and arterial system: angiographic and pathologic findings in a swine model. Cardiovascular Pathology 2008;17:206-11. [DOI: 10.1016/j.carpath.2007.09.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
12 Ding PX, Zhang SJ, Li Z, Fu MT, Hua ZH, Zhang WG. Long-term safety and outcome of percutaneous transhepatic venous balloon angioplasty for Budd-Chiari syndrome. J Gastroenterol Hepatol 2016;31:222-8. [PMID: 26102208 DOI: 10.1111/jgh.13025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
13 Jahangiri Y, Kerrigan T, Li L, Prosser D, Brar A, Righetti J, Schenning RC, Kaufman JA, Farsad K. Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation. Cardiovasc Diagn Ther. 2017;7:S150-S158. [PMID: 29399518 DOI: 10.21037/cdt.2017.10.03] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
14 He X, Li W, Peng W, Li Y, Tan H. Anticoagulation With Warfarin for Budd–Chiari Syndrome with Chronic Inferior Vena Cava Thrombosis: An Initial Clinical Experience. Annals of Vascular Surgery 2011;25:359-65. [DOI: 10.1016/j.avsg.2010.07.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
15 Wang L, Xiao Z, Yue Z, Zhao H, Fan Z, Zhao M, He F, Dai S, Qiu B, Yao J, Lin Q, Dong X, Liu F. Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial. Sci Rep. 2016;6:21011. [PMID: 26876503 DOI: 10.1038/srep21011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
16 Geeroms B, Laleman W, Laenen A, Heye S, Verslype C, van der Merwe S, Nevens F, Maleux G. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results. Eur Radiol 2017;27:1795-803. [PMID: 27629421 DOI: 10.1007/s00330-016-4570-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
17 Nicolas C, d’Alteroche L, Perarnau J. Reply to: “Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials?”. Journal of Hepatology 2015;62:247-8. [DOI: 10.1016/j.jhep.2014.09.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Wu X, Ding W, Cao J, Han J, Huang Q, Li N, Li J. Favorable clinical outcome using a covered stent following transjugular intrahepatic portosystemic shunt in patients with portal hypertension. J Hepatobiliary Pancreat Sci. 2010;17:701-708. [PMID: 20703849 DOI: 10.1007/s00534-010-0270-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
19 Ede CJ, Nikolova D, Brand M. Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis. Cochrane Database Syst Rev 2018;8:CD011717. [PMID: 30073663 DOI: 10.1002/14651858.CD011717.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Rössle M. TIPS: 25years later. Journal of Hepatology 2013;59:1081-93. [DOI: 10.1016/j.jhep.2013.06.014] [Cited by in Crossref: 184] [Cited by in F6Publishing: 142] [Article Influence: 23.0] [Reference Citation Analysis]
21 Saad WE, Wagner CC, Lippert A, Al-Osaimi A, Davies MG, Matsumoto AH, Angle JF, Caldwell S. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol. 2013;108:1612-1619. [PMID: 23939627 DOI: 10.1038/ajg.2013.232] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
22 Wang CM, Li X, Fu J, Luan JY, Li TR, Zhao J, Dong GX. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis. Chin Med J (Engl) 2016;129:1261-7. [PMID: 27231160 DOI: 10.4103/0366-6999.182830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
23 D’Amico G, Luca A. TIPS is a cost effective alternative to surgical shunt as a rescue therapy for prevention of recurrent bleeding from esophageal varices. J Hepatol. 2008;48:387-390. [PMID: 18199520 DOI: 10.1016/j.jhep.2007.12.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
24 Mermuys K, Maleux G, Heye S, Lombaerts R, Nevens F. Use of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience. Cardiovasc Intervent Radiol. 2008;31 Suppl 2:S192-S196. [PMID: 18183459 DOI: 10.1007/s00270-007-9262-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
25 Heinzow HS, Lenz P, Köhler M, Reinecke F, Ullerich H, Domschke W, Domagk D, Meister T. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. World J Gastroenterol. 2012;18:5211-5218. [PMID: 23066315 DOI: 10.3748/wjg.v18.i37.5211] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
26 Orloff MJ, Isenberg JI, Wheeler HO, Daily PO, Girard B. Budd–Chiari Syndrome Revisited: 38 Years’ Experience with Surgical Portal Decompression. J Gastrointest Surg 2012;16:286-300. [DOI: 10.1007/s11605-011-1738-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
27 Perello MP, Mur JP, Vives MS, Riutort JMM, Artigues AP, Garcia CN, Vidal MLB, Gelabert AE, Garau MV. Long-term follow-up of transjugular intrahepatic portosystemic shunt (TIPS) with stent-graft. Diagn Interv Radiol 2019;25:346-52. [PMID: 31322502 DOI: 10.5152/dir.2019.18416] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
28 Sommer CM, Gockner TL, Stampfl U, Bellemann N, Sauer P, Ganten T, Weitz J, Kauczor HU, Radeleff BA. Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus viatorr stent-grafts (VSG). Eur J Radiol. 2012;81:2273-2280. [PMID: 21784593 DOI: 10.1016/j.ejrad.2011.06.037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
29 Wu X, Ding W, Cao J, Fan X, Li J. Clinical Outcome Using the Fluency Stent Graft for Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension. The American Surgeon 2013;79:305-12. [DOI: 10.1177/000313481307900332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
30 Carnevale FC, Szejnfeld D, Moreira AM, Gibelli N, De Gregório MA, Tannuri U, Cerri GG. Long-term follow-up after successful transjugular intrahepatic portosystemic shunt placement in a pediatric patient with Budd-Chiari syndrome. Cardiovasc Intervent Radiol 2008;31:1244-8. [PMID: 18756372 DOI: 10.1007/s00270-008-9400-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
31 Ding PX, He X, Han XW, Zhang Y, Wu Y, Liang XX, Liu C. An Individualised Strategy and Long-Term Outcomes of Endovascular Treatment of Budd-Chiari Syndrome Complicated by Inferior Vena Cava Thrombosis. Eur J Vasc Endovasc Surg. 2018;55:545-553. [PMID: 29478911 DOI: 10.1016/j.ejvs.2017.12.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
32 Saad WE, Darwish WM, Davies MG, Kumer S, Anderson C, Waldman DL, Schmitt T, Matsumoto AH, Angle JF. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol. 2013;200:210-218. [PMID: 23255764 DOI: 10.2214/ajr.11.7653] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
33 Buechter M, Manka P, Gerken G, Canbay A, Blomeyer S, Wetter A, Altenbernd J, Kahraman A, Theysohn JM. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience. Dig Dis 2018;36:218-27. [PMID: 29316565 DOI: 10.1159/000486030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
34 Hashimoto N, Akahoshi T, Yoshida D, Kinjo N, Konishi K, Uehara H, Nagao Y, Kawanaka H, Tomikawa M, Maehara Y. The efficacy of balloon-occluded retrograde transvenous obliteration on small intestinal variceal bleeding. Surgery. 2010;148:145-150. [PMID: 20004438 DOI: 10.1016/j.surg.2009.10.052] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
35 Gordon BM, Fishbein MC, Levi DS. Serial late dilatations of expanded polytetrafluoroethylene-covered stents in porcine aorta: Dilatation of Atrium ePTFE-Covered Stents. Cathet Cardiovasc Intervent 2008;72:400-7. [DOI: 10.1002/ccd.21658] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
36 Buscaglia JM, Dray X, Shin EJ, Magno P, Chmura KM, Surti VC, Dillon TE, Ducharme RW, Donatelli G, Thuluvath PJ. A new alternative for a transjugular intrahepatic portosystemic shunt: EUS-guided creation of an intrahepatic portosystemic shunt (with video). Gastrointest Endosc. 2009;69:941-947. [PMID: 19327481 DOI: 10.1016/j.gie.2008.09.051] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
37 Syed MI, Karsan H, Ferral H, Shaikh A, Waheed U, Akhter T, Gabbard A, Morar K, Tyrrell R. Transjugular intrahepatic porto-systemic shunt in the elderly: Palliation for complications of portal hypertension. World J Hepatol. 2012;4:35-42. [PMID: 22400084 DOI: 10.4254/wjh.v4.i2.35] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
38 Ghannam JS, Cline MR, Hage AN, Chick JFB, Srinivasa RN, Dasika NL, Srinivasa RN, Gemmete JJ. Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience. Pediatr Radiol 2019;49:128-35. [DOI: 10.1007/s00247-018-4267-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Owen JW, Saad NE, Foster G, Fowler KJ. The Feasibility of Using Volumetric Phase-Contrast MR Imaging (4D Flow) to Assess for Transjugular Intrahepatic Portosystemic Shunt Dysfunction. J Vasc Interv Radiol 2018;29:1717-24. [PMID: 30396843 DOI: 10.1016/j.jvir.2018.07.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Di Giorgio A, Agazzi R, Alberti D, Colledan M, D’antiga L. Feasibility and Efficacy of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Children. Journal of Pediatric Gastroenterology & Nutrition 2012;54:594-600. [DOI: 10.1097/mpg.0b013e3182490c05] [Cited by in Crossref: 43] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
41 Brand M, Prodehl L, Ede CJ. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis. Cochrane Database Syst Rev 2018;10:CD001023. [PMID: 30378107 DOI: 10.1002/14651858.CD001023.pub3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
42 Krajina A, Hulek P, Fejfar T, Valek V. Quality improvement guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS). Cardiovasc Intervent Radiol. 2012;35:1295-1300. [PMID: 23070105 DOI: 10.1007/s00270-012-0493-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
43 Gur I, Diggs BS, Orloff SL. Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant. HPB (Oxford). 2014;16:481-493. [PMID: 23961811 DOI: 10.1111/hpb.12163] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
44 Fanelli F. The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips. ISRN Hepatol 2014;2014:762096. [PMID: 27335841 DOI: 10.1155/2014/762096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
45 Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017;9:603-12. [PMID: 28515846 DOI: 10.4254/wjh.v9.i12.603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Wu X, Han J, Cao J, Wu X, Li W, Sun J, Li J. Combined TIPS with portal-azygous disconnection improved the long term clinical outcome in portal hypertension patients. J Hepatobiliary Pancreat Surg. 2009;16:858-864. [PMID: 19789834 DOI: 10.1007/s00534-009-0189-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Saad WE, Darwish WM, Davies MG, Waldman DL. Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination. J Vasc Interv Radiol. 2010;21:1512-1520. [PMID: 20801686 DOI: 10.1016/j.jvir.2010.06.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]